BWAY News and Press, BrainsWay Ltd. From 05/24/23

2023-05-24 23:59:08 ET Summary BrainsWay has had a difficult 12 months, as a tough macro environment has overly impacted its customer base, which skews towards smaller companies. A return to growth and a renewed focus on profitability should begin moving BrainsWay towards breakeve...

2023-05-23 07:53:54 ET BrainsWay ( NASDAQ: BWAY ) said on Tuesday that the neurostimulation treatments company has appointed Ido Marom CFO. Marom succeeds Scott Areglado, who is set to step down to pursue other opportunities. Most recently, Marom served as C...

BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment o...

2023-05-17 12:46:02 ET BrainsWay Ltd. (BWAY) Q1 2023 Earnings Call May 17, 2023 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Hadar Levy - Chief Executive Officer Scott Areglado - Senior Vice President and Chief Financial Of...

2023-05-17 07:34:43 ET Brainsway press release ( NASDAQ: BWAY ): Q1 GAAP EPS of -$0.07 beats by $0.04 . Revenue of $6.6M (-17.5% Y/Y) beats by $0.2M . The Company shipped a net total of 48 Deep TMS new systems during the first quarter of 2023, bringing BrainsWa...

BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported first quarter 2023 financial results and...

BURLINGTON, Mass. and JERUSALEM, May 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the launch of its...

BURLINGTON, Mass. and JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will repo...

BURLINGTON, Mass. and JERUSALEM, Israel, May 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its parti...

Real-World Evidence Demonstrates the Highest Response and Remission Rates Observed to Date for Deep BURLINGTON, Mass. and JERUSALEM, March 28, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in...